New monoclonal antibodies for hematologic malignancies (and breast cancer)
Curtis, M.A.
Medicine and Health Rhode Island 86(8): 256-257
2003
ISSN/ISBN: 1086-5462 PMID: 14582224 Document Number: 553315
Document emailed within 1 workday
Related Documents
Moroz, C.; Bessler, H.; Lurie, Y.; Shaklai, M. 1987: New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies Experimental Hematology 15(3): 258-262Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
Jakovljevic, M.; Gutzwiller, F.; Schwenkglenks, M.; Milovanovic, O.; Rancic, N.; Varjacic, M.; Stojadinovic, D.; Dagovic, A.; Matter-Walstra, K. 2014: Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma Journal of BUON: Official Journal of the Balkan Union of Oncology 19(4): 1111-1120
Herlyn, M.; Shen, J.W.; Sears, H.F.; Civin, C.I.; Verrill, H.L.; Goldberg, E.M.; Koprowski, H. 1984: Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants Clinical and Experimental Immunology 55(1): 23-35
Ohtsu, T.; Shimoyama, M.; Hamada, H.; Sugimoto, Y.; Ohkochi, E.; Tsuruo, T.; Ishida, Y.; Tobinai, K.; Minato, K. 1988: Detection of drug resistance in human hematologic malignancy by monoclonal antibodies Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1630-1640
Grammatikakis, I.; Zervoudis, S.; Kassanos, D. 2010: Synopsis of new antiangiogenetic factors, mutation compensation agents, and monoclonal antibodies in target therapies of breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(4): 639-646
Burchell, J.; Gendler, S.; Taylor-Papadimitriou, J.; Girling, A.; Lewis, A.; Millis, R.; Lamport, D. 1987: Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin Cancer Research 47(20): 5476-5482
Kuzel, T.M.; Duda, R.B. 1992: The current status of radiolabeled monoclonal antibodies for the diagnosis and treatment of human malignancies Comprehensive Therapy 18(6): 16-20
Murakami, H.; Saitoh, T.; Kasamatsu, T. 2016: Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 539-544
Usui, N. 2017: Hematologic Malignancies/Pediatric Malignancies Acute Leukemia - Current Treatment and Future Perspective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(5): 378-379
Usui, N. 2011: Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 744
Noel, P.; Tabone, E.; Michot, J.P.; Groleas, M.; Hesch, M.; Rifki, A.M. 1989: Detection of micrometastases in excised regional lymph nodes in cancer of the breast. Systematic use of KL1 anticytokeratin monoclonal antibodies in a prospective series of 120 T2 N- patients Annales de Pathologie 9(4): 265-270
Donner, L.; Triche, T.J.; Israel, M.A.; Seeger, R.C.; Reynolds, C.P. 1985: A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies Progress in Clinical and Biological Research 175: 347-366
Huber, H.; Gattringer, C.; Thaler, J.; Peschel, C. 1985: Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms Behring Institute Mitteilungen 78: 83-117
Usui, N. 2009: Hematologic malignancies/pediatric malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 742-743
Agius, M.A.; Geannopoulos, C.J.; Fairclough, R.H.; Richman, D.P. 1988: Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding Journal of Immunology 140(1): 62-68
James, K. 1990: Human monoclonal antibodies and engineered antibodies in the management of cancer Seminars in Cancer Biology 1(3): 243-253
Sampi, K. 1987: Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 951-955
Papsidero, L.D.; Croghan, G.A.; O'Connell, M.J.; Valenzuela, L.A.; Nemoto, T.; Chu, T.M. 1983: Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma Cancer Research 43(4): 1741-1747
Rasmussen, B.B. 1986: Monoclonal antibodies to human breast epithelium Ugeskrift for Laeger 148(26): 1592-1595